Open AccessEURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)
Author(s) -
В. В. Кухарчук,
M. Ezhov,
И. В. Сергиенко,
Г. Г. Арабидзе,
Т. В. Балахонова,
В. С. Гуревич,
Parounak Zelveian,
Т. М. Мураталиев,
Г. Ш. Мырзахметова,
О А Суджаева,
Aleksandr B. Shek,
Azizov Va,
Н. Б. Горнякова,
М. А. Качковский,
П. П. Малышев,
С. Н. Покровский,
А. А. Соколов,
А. Б. Сумароков,
А. Г. Обрезан,
И. И. Шапошник,
М. Б. Анциферов,
А. А. Аншелес,
Д. М. Аронов,
Н. М. Ахмеджанов,
О. Л. Барбараш,
С. А. Бойцов,
М. Г. Бубнова,
М. И. Воевода,
Г. Р. Галстян,
А. С. Галявич,
О. М. Драпкина,
Д. В. Дупляков,
С. Я. Ерёгин,
Р. С. Карпов,
Ю. А. Карпов,
Н. А. Козиолова,
G A Konovalov,
В. О. Константинов,
Е. Д. Космачёва,
С. В. Недогода,
В. Э. Олейников,
Ю. И. Рагино,
В. В. Скибицкий,
О. Г. Смоленская,
Ю. Ш. Халимов,
И. Е. Чазова,
Alexander É. Filippov,
Marina V. Shestakova,
С. С. Якушин
Publication year - 2020
Publication title -
evrazijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2305-0748
pISSN - 2225-1685
DOI - 10.38109/2225-1685-2020-2-6-29
Subject(s) - medicine , disclaimer , health care , public health , medical prescription , political science , nursing , law
Disclaimer РThe EAC/RNAS Guidelines represent the views of the EAC and RNAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC and RNAS is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the EAC/RNAS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EAC/RNAS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the EAC/RNAS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the EAC/RNAS Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription. Members of the Working Group confirmed the lack of financial support / conflict of interest. In the event of a conflict of interest being reported, the member (s) of the Working Group was (were) excluded from the discussion of sections related to the area of conflict of interest.